𝔖 Bobbio Scriptorium
✦   LIBER   ✦

PI3K/Akt signaling as a key regulatory pathway for chondrocyte terminal differentiation

✍ Scribed by Keisuke Kita; Tohru Kimura; Norimasa Nakamura; Hideki Yoshikawa; Toru Nakano

Book ID
108732028
Publisher
John Wiley and Sons
Year
2008
Tongue
English
Weight
439 KB
Volume
13
Category
Article
ISSN
1356-9597

No coin nor oath required. For personal study only.

πŸ“œ SIMILAR VOLUMES

The Src/PI3K/Akt signal pathway may play
The Src/PI3K/Akt signal pathway may play a key role in decreased drug efficacy in obesity-associated cancer
✍ Jiezhong Chen πŸ“‚ Article πŸ“… 2010 πŸ› John Wiley and Sons 🌐 English βš– 40 KB

O besity not only results in increased incidence but also leads to poor prognosis of many cancers. The increased cancer incidence in obesity is accounted for by the activation of cellular signal pathways which are carcinogenic such as Src/PI3K/Akt pathway [Chen, 2008; Huang and Chen, 2009b]. However

FGFR1/PI3K/AKT signaling pathway is a no
FGFR1/PI3K/AKT signaling pathway is a novel target for antiangiogenic effects of the cancer drug Fumagillin (TNP-470)
✍ Gregory J. Chen; Brian Weylie; Chen Hu; James Zhu; Reza Forough πŸ“‚ Article πŸ“… 2007 πŸ› John Wiley and Sons 🌐 English βš– 279 KB πŸ‘ 1 views

## Abstract Fibroblast growth factor‐1 (FGF1), a prototypic member of the FGF family, is a potent angiogenic factor. Although FGF‐stimulated angiogenesis has been extensively studied, the molecular mechanisms regulating FGF1‐induced angiogenesis are poorly understood in vivo. Fumagillin, an antiang